Intrexon to Present at the 2014 J.P. Morgan Healthcare Conference
GERMANTOWN, Md., Jan. 7, 2014
GERMANTOWN, Md., Jan. 7, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE:
XON), a leader in synthetic biology, announced today that Randal J. Kirk,
Chairman and Chief Executive Officer of Intrexon, will present at the J.P.
Morgan Healthcare Conference on Wednesday, January 15, at 1:30 p.m. Pacific
Standard Time at the Westin St. Francis in San Francisco.
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on
collaborating with companies in Health, Food, Energy and the Environment to
create biologically-based products that improve the quality of life and the
health of the planet. Through the company's proprietary UltraVector®
platform, Intrexon provides its partners with industrial-scale design and
development of complex biological systems. The UltraVector® platform delivers
unprecedented control over the quality, function, and performance of living
cells. We call our synthetic biology approach and integrated technologies
Better DNA®, and we invite you to discover more www.DNA.com.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking
statements. These forward-looking statements are based upon our current
expectations and projections about future events and generally relate to our
plans, objectives and expectations for the development of our business.
Although management believes that the plans and objectives reflected in or
suggested by these forward-looking statements are reasonable, all
forward-looking statements involve risks and uncertainties and actual future
results may be materially different from the plans, objectives and
expectations expressed in this press release.
V.P. Corporate Communication
Tel: +1 561-410-7023
SOURCE Intrexon Corporation
Press spacebar to pause and continue. Press esc to stop.